HomeNWRN • SWX
add
Newron Pharmaceuticals SpA
Previous close
CHFÂ 14.30
Day range
CHFÂ 14.10 - CHFÂ 14.40
Year range
CHFÂ 5.20 - CHFÂ 16.00
Market cap
285.44M CHF
Avg Volume
163.90K
P/E ratio
17.96
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 5.95M | 249.22% |
Operating expense | 5.28M | -4.84% |
Net income | -36.50K | 99.24% |
Net profit margin | -0.61 | 99.78% |
Earnings per share | — | — |
EBITDA | 715.00K | 118.85% |
Effective tax rate | -28.07% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 43.20M | 254.41% |
Total assets | 61.39M | 146.20% |
Total liabilities | 59.81M | 7.25% |
Total equity | 1.58M | — |
Shares outstanding | 19.96M | — |
Price to book | 178.75 | — |
Return on assets | 2.74% | — |
Return on capital | 3.10% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -36.50K | 99.24% |
Cash from operations | 16.68M | 477.81% |
Cash from investing | -6.78M | -774.61% |
Cash from financing | -47.00K | -101.12% |
Net change in cash | 9.85M | 1,164.02% |
Free cash flow | -170.50K | 94.23% |
About
CEO
Founded
1999
Website
Employees
22
